top of page
Search

Novo Nordisk, AWS Partner on AI Drug Discovery

August 14, 2026 | njbiz.com





Novo Nordisk is deepening its push into artificial intelligence through a new strategic partnership with Amazon Web Services. The collaboration aims to accelerate drug discovery and expand the use of AI across the pharmaceutical company. 


The collaboration includes a new co-innovation hub at Novo Nordisk’s facility in London. There, AWS engineers, AI specialists and scientists will work with the pharma giant’s research teams to analyze scientific data and help accelerate drug discovery.


Read More: Click Here


NJ SEED: The article illustrates how one major company is using AI creatively to aid in drug development and distribution.

 
 
 

Recent Posts

See All
42 NJ Companies Named Among Forbes’ Top Employers

July 14, 2026 | njbiz.com Among companies doing business in New Jersey, organizations based here account for nearly half of those named to Forbes’ 2026 list of best employers by state. Now in its eig

 
 
 

Comments


bottom of page